Camtek
CAMT
152.20
-2.35
-1.52%
Camtek
US · CAMT
#1702 by market cap
Listed 1970
152.20
-2.35
-1.52%
Live - 5344 symbols - heartbeat 357s ago
· 2026-10-08 06:38
Pre-market
148.71
-2.29%
After-hours
152.20
0.00%
Overnight
152.70
+0.33%
- Market cap
- 7.10B
- P/E (TTM)i
- 205.68
- P/Bi
- 10.00
- EPSi
- 1.04
- Div yieldi
- 0.00%
- 52W posi
- 49%
Reader sentiment
Are you bullish or bearish on CAMT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 8.54, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +15.57% YoY
Margins
- Gross margin
- 50.46%
- Operating margin
- 25.84%
- Net margin
- 10.22%
Key ratios & quality
- Enterprise valuei
- 6.96B
- Altman Z-Scorei
- 8.54
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 123.17M | 134.02M | 155.86M | 269.66M | 320.91M | 315.38M | 429.23M | 496.07M |
| Gross profit | 60.80M | 64.78M | 73.23M | 137.34M | 159.86M | 147.63M | 209.95M | 250.32M |
| Selling & admin expenses | 26.18M | 26.48M | 31.03M | 42.97M | 49.50M | 50.75M | 63.60M | 73.77M |
| Research & development | 14.58M | 16.33M | 19.58M | 23.47M | 28.86M | 31.47M | 38.29M | 48.35M |
| Operating profit | 20.03M | 21.97M | 22.62M | 70.90M | 81.50M | 65.41M | 108.07M | 128.20M |
| Pretax profit | 20.76M | 22.77M | 23.40M | 71.93M | 88.19M | 87.63M | 131.24M | 52.34M |
| Tax | 2.03M | 1.95M | 1.62M | 11.65M | 8.24M | 9.00M | 12.72M | 1.61M |
| Net profit | 18.73M | 21.99M | 21.78M | 60.28M | 79.95M | 78.63M | 118.52M | 50.72M |
| Basic EPS | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 1 |
| Diluted EPS | 0.51 | 0.57 | 0.54 | 1.34 | 1.68 | 1.63 | 2.42 | 1.04 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 118.64M | 123.32M | 125.99M | 128.12M | 121.66M | 133.24M |
| Gross profit | 60.56M | 62.61M | 63.04M | 64.10M | 60.93M | 66.70M |
| Selling & admin expenses | 17.50M | 19.16M | 17.74M | 19.36M | 19.34M | 22.79M |
| Research & development | 10.36M | 11.47M | 13.45M | 13.06M | 14.32M | 16.68M |
| Operating profit | 32.70M | 31.97M | 31.85M | 31.68M | 27.27M | 27.23M |
| Pretax profit | 38.13M | 36.92M | -62.56M | 39.85M | 35.42M | 34.20M |
| Tax | 3.82M | 3.22M | -9.38M | 3.95M | 3.77M | 10.90M |
| Net profit | 34.31M | 33.70M | -53.18M | 35.90M | 31.65M | 23.31M |
| Basic EPS | 1 | 1 | -1 | 1 | 1 | 1 |
| Diluted EPS | 0.70 | 0.69 | -1.16 | 0.71 | 0.63 | 0.46 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 119.30M | 147.70M | 261.92M | 520.18M | 556.96M | 546.79M | 620.06M | 897.00M |
| Cash & ST investments | 54.94M | 89.55M | 177.82M | 397.94M | 399.66M | 354.03M | 388.04M | 668.16M |
| Inventory | 30.11M | 23.80M | 39.74M | 58.76M | 65.54M | 85.91M | 111.20M | 112.20M |
| Total assets | 141.55M | 170.37M | 287.91M | 583.76M | 677.09M | 787.67M | 892.04M | 1.26B |
| Total current liabilities | 38.72M | 31.61M | 57.38M | 89.69M | 88.50M | 96.67M | 123.91M | 107.43M |
| Short-term debt | -- | 826.00K | 736.00K | 1.02M | 1.30M | 1.69M | 2.49M | 2.12M |
| Long-term debt | -- | -- | -- | 194.64M | 195.74M | 196.83M | 197.93M | 519.83M |
| Total liabilities | 40,140,000.00 | 34,067,000.00 | 60,644,000.00 | 290,130,000.00 | 292,985,000.00 | 311,519,000.00 | 342,807,000.00 | 642,830,000.00 |
| Total equity | 101.41M | 136.30M | 227.26M | 293.63M | 384.10M | 476.15M | 549.24M | 617.00M |
| Retained earnings | 21.28M | 36.72M | 58.49M | 118.77M | 198.72M | 277.35M | 335.82M | 386.54M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 673.99M | 702.94M | 899.83M | 897.00M | 937.48M | 924.42M |
| Cash & ST investments | 421.54M | 435.99M | 639.49M | 668.16M | 670.26M | 630.36M |
| Inventory | 129.18M | 133.71M | 126.49M | 112.20M | 99.98M | 99.82M |
| Total assets | 934.02M | 974.74M | 1.23B | 1.26B | 1.30B | 1.34B |
| Total current liabilities | 127.73M | 129.98M | 118.70M | 107.43M | 112.27M | 125.34M |
| Short-term debt | -- | 2.21M | -- | 2.12M | -- | -- |
| Long-term debt | 198.20M | 198.47M | 519.11M | 519.83M | 487.81M | 488.50M |
| Total liabilities | 346,099,000.00 | 348,257,000.00 | 653,026,000.00 | 642,830,000.00 | 615,532,000.00 | 628,889,000.00 |
| Total equity | 587.92M | 626.48M | 578.04M | 617.00M | 682.53M | 710.16M |
| Retained earnings | 370.13M | 403.83M | 350.65M | 386.54M | 418.19M | 441.49M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 16.79M | 24.63M | 25.75M | 60.96M | 57.80M | 79.32M | 122.24M | 141.87M |
| Depreciation & amortization | 1.97M | 2.13M | 2.23M | 2.81M | 4.09M | 5.78M | 10.67M | 11.78M |
| Free cash flow | 14.46M | 23.26M | 23.13M | 56.78M | 49.51M | 71.05M | 111.88M | 127.07M |
| Dividends paid | -5.06M | -6.55M | -- | -- | 0 | 0 | -60.05M | 0 |
| Stock buybacks / issuance | 0 | 16.03M | 64.29M | -- | -- | -- | -- | -- |
| Ending cash balance | 54.94M | 38.05M | 105.82M | 241.94M | 148.16M | 119.97M | 126.22M | 177.85M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | -- | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | -- | -- | -- | -- | -- | -- |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | -- | -- | -- | -- | -- | -- |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 20.17 | 18.50 | 11.98 | 23.14 | 23.59 | 18.28 | 23.12 | 8.70 |
| ROA %i | 14.72 | 14.10 | 9.50 | 13.83 | 12.68 | 10.74 | 14.11 | 4.71 |
| ROIC %i | 19.60 | 17.29 | 11.23 | 16.42 | 13.69 | 9.30 | 13.54 | 2.54 |
| 5-year avg ROE %i | 6.94 | 9.59 | 15.01 | 18.30 | 19.48 | 19.10 | 20.02 | 19.37 |
| EBIT margin %i | 16.86 | 16.99 | 14.52 | 26.29 | 27.98 | 28.34 | 30.83 | 10.88 |
| FCF / sales %i | 11.74 | 17.36 | 14.84 | 21.06 | 15.43 | 22.53 | 26.06 | 25.62 |
| Current ratioi | 3.08 | 4.67 | 4.56 | 5.80 | 6.29 | 5.66 | 5.00 | 8.35 |
| Quick ratioi | 2.29 | 3.90 | 3.86 | 5.12 | 5.50 | 4.69 | 4.05 | 7.26 |
| Debt / assetsi | 0.00 | 0.94 | 0.49 | 33.85 | 29.46 | 25.54 | 23.21 | 42.13 |
| LT debt / equityi | -- | 0.57 | 0.30 | 66.94 | 51.59 | 41.89 | 37.25 | 85.68 |
| Interest coveragei | -- | -- | -- | -- | 55.88 | 50.93 | 120.96 | 32.60 |
| Revenue CAGR (3Y) %i | 21.08 | 19.15 | 18.58 | 29.85 | 33.78 | 26.48 | 16.76 | 15.63 |
| Net income CAGR (3Y) %i | -- | 66.84 | 15.97 | 47.64 | 53.78 | 53.41 | 25.28 | -14.07 |
| FCF CAGR (3Y) %i | -- | -- | -- | 57.78 | 28.62 | 45.38 | 25.37 | 36.92 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 24.82 | 24.28 | 8.76 | 8.70 | 7.57 | 5.64 |
| ROA %i | 14.63 | 15.11 | 4.62 | 4.71 | 4.31 | 3.26 |
| ROIC %i | 14.84 | 14.85 | 2.67 | 2.54 | 1.77 | 1.04 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 31.89 | 31.73 | 31.34 | 10.88 | 9.73 | 8.61 |
| FCF / sales %i | -- | 18.72 | -- | 25.62 | -- | -- |
| Current ratioi | 5.28 | 5.41 | 7.58 | 8.35 | 8.35 | 7.38 |
| Quick ratioi | 4.09 | 4.34 | 6.34 | 7.26 | 7.14 | 6.26 |
| Debt / assetsi | 21.22 | 20.59 | 42.17 | 42.13 | 37.58 | 36.48 |
| LT debt / equityi | 33.71 | 31.68 | 89.81 | 85.68 | 71.47 | 68.79 |
| Interest coveragei | -- | 136.78 | -- | 32.60 | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Sales of products is the largest reported line at 94.44% of revenue, across 2 reported segments.
- The next-largest line, Service fees, is a distant second at 5.56% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Sales of products94.44%
Service fees5.56%
Region
China49.17%
Asia Pacific34.06%
Korea7.44%
United States5.81%
Europe3.52%
Quote time 2026-10-08 06:38:12 · For reference only, not investment advice and not tailored to your situation.